3Sixty Pharma Solutions Partners with Westchester Biotech Project

Leveraging its “360Start-Up” Powerhouse to Grow a Dynamic Non-Profit for Scientists

Conshohocken, PA, January 11, 2020 --(PR.com)-- 3Sixty Pharma Solutions LLC,
www.3sixtypharma.com, today announced an exciting new partnership with Westchester Biotech Project.
The company's 360Start-Up arm is helping the non-profit navigate the complexities and challenges
common to start-up and growth-phase life science companies. 360Start-Up accelerates product
development, boosts commercialization and marketing operations, and drives product launch for
burgeoning companies and organizations. The partnership promises to reinforce Westchester Biotech
Project's own efforts to serve the scientific community by focusing locally to enable global engagement.

Both 3Sixty Pharma Solutions and Westchester Biotech Project support institutions, companies, and
careers that impact today's and tomorrow's researchers, data scientists, engineers, and entrepreneurs - as
well as the people and entities responsible for stimulating and nurturing a cross-cultural, international,
science-focused cluster.

Dalfoni Banerjee, 3Sixty Pharma Solutions' Principal Consultant & CEO, reflected on the collaboration:
“As Joanne Gere (Westchester Biotech Project's Executive Director) and I have gotten to know each other
through projects we've done across several years, we've come to realize the unmistakable synergies.”

Westchester Biotech Project champions borderless, cross-silo collaborations throughout biomedical

research and development, which will now be powered by the 360Start-Up engine. “Dal's team handles
operations management with foresight and patience that allows us to strategize and implement
foundational processes without extra stress,” said Joanne Gere. “Their expertise, energy, and vision
support our mission, while at the same time expanding and strengthening our capabilities. It's a great fit.”

Ongoing and planned initiatives include educational programs on research, product development, and
funding. Additionally, 360Start-Up leads Westchester Biotech Project's strategic planning, internal
infrastructure development, and project management for the organization's Data Science Research Hub.

About 3Sixty Pharma Solutions

3Sixty Pharma Solutions is a privately-held, US-based life sciences consulting firm whose mission is to
accelerate and support the development of medicines and therapies, boost operations efficiency, and drive
product launch for start-up and established pharmaceutical, biotechnology, medical device, and other life
science companies. With core capabilities in science, project management, and communications, our
niche is the ability to channel clients' pain-points out of the critical path of their routine activities into the
hands of seasoned experts who are bolstered by a robust process structure that assures quality and
timeliness. We're here for our clients when they need nimble support and experienced helping hands.

Further information about 3Sixty Pharma Solutions can be found at www.3sixtypharma.com.

About Westchester Biotech Project

Page 1/3
PR.com Press Release Distribution Terms of Use
Westchester Biotech Project champions borderless, cross-silo collaborations throughout biomedical
research and development. The non-profit organization partners with academic, industry, nonprofit, and
government entities to stimulate inspiring and practical collaborations. Throughout 2020, Roundtables
and Symposia will address Rare Disease Research, Advancing Microbiome Science to Clinical Practice,
Education Strategies for a Vibrant Cluster, and a new Data Science Research Hub. The Biotech Blueprint
2030 brings together a diverse community to dream big. www.westchesterbiotechproject.org

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
3Sixty Pharma Solutions
Eric Smith, Vice President, Communications
610-941-4750
Contact via Email
3sixtypharma.com
LinkedIn: www.linkedin.com/company/3sixty-pharma-solutions-llc
Twitter: @3SixtyPharma

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/803059

News Image:

Page 3/3
PR.com Press Release Distribution Terms of Use